» Articles » PMID: 12663492

Oxidative Stress and Ulcerative Colitis-associated Carcinogenesis: Studies in Humans and Animal Models

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2003 Mar 29
PMID 12663492
Citations 163
Authors
Affiliations
Soon will be listed here.
Abstract

The chronic inflammatory bowel disease ulcerative colitis (UC) occurs commonly in the US and other Western countries, but its etiology is unknown. An association between UC and an elevated risk for colorectal cancer is well established. UC-associated colorectal carcinogenesis is probably driven by chronic inflammation, but the mechanism is unclear. The morphological development of UC-associated cancer differs from that of its sporadic counterpart. Similarly, detailed molecular analyses have indicated that whereas many of the genetic alterations observed in sporadic colon cancers also occur in UC-associated neoplasms, the timing and frequency of those changes in the setting of UC are different. These histological and molecular signatures may very well be reflective of an inflammation-driven carcinogenesis process in UC patients. Studies in animal models of UC have helped to shed light on the mechanisms of inflammation-driven colorectal carcinogenesis. The available evidence suggests that DNA damage caused by oxidative stress in the characteristic damage-regeneration cycle is a major contributor to colorectal cancer development in UC patients. Based on this concept, iron over-nutrition is proposed as a risk factor and dietary antioxidants as protective factors for UC and associated carcinogenesis.

Citing Articles

Amelioration of inflammatory bowel disease by subsp. XLTG11 in combination with mesalazine.

Ma W, Wu Y, Lin X, Yang L, Huang L Front Microbiol. 2024; 15:1472776.

PMID: 39697653 PMC: 11652597. DOI: 10.3389/fmicb.2024.1472776.


Panduratin A mitigates inflammation and oxidative stress in DSS-induced colitis mice model.

Alqudah A, Qnais E, Gammoh O, Bseiso Y, Wedyan M, Oqal M Future Sci OA. 2024; 10(1):2428129.

PMID: 39559852 PMC: 11581177. DOI: 10.1080/20565623.2024.2428129.


APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.

Sahakian L, Robinson A, Sahakian L, Stavely R, Kelley M, Nurgali K Biomolecules. 2023; 13(11).

PMID: 38002251 PMC: 10669584. DOI: 10.3390/biom13111569.


A Short-Term Model of Colitis-Associated Colorectal Cancer That Suggests Initial Tumor Development and the Characteristics of Cancer Stem Cells.

Matsumoto Y, Fukui T, Horitani S, Tanimura Y, Suzuki R, Tomiyama T Int J Mol Sci. 2023; 24(14).

PMID: 37511456 PMC: 10380789. DOI: 10.3390/ijms241411697.


Rapid Screening of Proanthocyanidins from the Roots of Stapf and its Preventative Effects on Dextran-Sulfate-Sodium-Induced Ulcerative Colitis.

Lv M, Wang Y, Wan X, Han B, Yu W, Liang Q Metabolites. 2022; 12(10).

PMID: 36295859 PMC: 9611049. DOI: 10.3390/metabo12100957.